Loss of thymic self-antigen presentation may drive muscle and metabolic decline
Restoring presentation of muscle and endocrine self-antigens in 80% of each thymic epithelial group may reduce new self-reactive T cells and improve muscle recovery and glucose regulation over weeks or months. Improvement within hours, or benefit persisting after self-reactive cell output returns, would refute it.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Specialised cell of an organ
Medullary thymic epithelial cells
Epithelial cells in the thymic medulla that present self-antigens during the screening of developing T cells
Where this hypothesis actsTwo functional groups presenting selected self-antigens from muscle and endocrine tissues
Hypotheses on this target 1
Function restoration1
Reprogramming
Transplantation
Elimination
Proliferation
What is proposed
Function restoration
Restore selected self-antigen presentation in both functional groups
With whatNot stated in the record
HowRestore presentation in 80% of cells in each group while preserving original cell numbers; the correction technique is not stated
Possible result
Possible reduced autoreactive T-cell output, improved muscle recovery and improved glucose regulation
From the recordПредлагаемый набор состоит из эпителиальных клеток мозгового вещества тимуса, представляющих собственные антигены мышечной и эндокринной тканей.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Muscle decline and difficulty controlling blood sugar might reinforce each other through immune attacks on the body's own tissues. The unexpected move is to repair selected cells in the thymus, the organ where certain immune cells mature, rather than repair the damaged tissues directly. This is a pipeline-generated hypothesis, not a measured result: it proposes that restoring two specific screening functions could provide benefits across systems without restoring the whole organ.
- Targeted correction restores display of selected muscle and hormone-producing-tissue samples in 80% of each proposed thymus cell group, while keeping cell numbers unchanged.
- Restored screening reduces the release of newly matured immune cells that attack those selected tissue samples.
- Fewer newly released self-attacking cells reduce immune damage to muscle and hormone-producing tissues.
- Reduced damage weakens the proposed mutual reinforcement between movement difficulties and disrupted blood-sugar control.
- Muscle recovery and blood-sugar regulation improve over weeks or months; any survival benefit requires separate confirmation.
The thymus is pictured as a training checkpoint with two sets of photographs showing places that must not be attacked. Restoring only one set leaves the other kind of mistaken attack possible.
Where the picture breaks: Immune cells do not recognize photographs or follow instructions. The picture does not establish that two separable cell groups are sufficient, that the proposed coverage works, or that correcting training removes self-attacking cells already outside the thymus.
- Master questionstep 01 of 04
A shared cause of several aging problems could offer a single target whose correction benefits multiple systems and extends life.
Rests on: The goal explicitly starts from the possibility that aging processes reinforce one another and that a shared causal link could be corrected.
Stated in the chain - Goal pillarstep 02 of 04
The intended output is a collection of life-extension ideas that act through distinct causes.
Rests on: The master question requests ideas for shared causal targets that could benefit several systems.
Stated in the chain - Gap questionstep 03 of 04
Specific tissues or cell groups become candidate targets only if correcting them and then switching off the proposed causal link can distinguish their effects on several body functions and lifespan from competing explanations.
Rests on: The preceding goal calls for causally distinct ideas; this stage adds requirements for locating and experimentally distinguishing them.
AssumptionTargeted correction followed by switching off the proposed causal link is adopted as the way to distinguish candidates. The preceding goal does not itself establish this testing requirement.
- Hypothesisstep 04 of 04
Two groups of thymus lining cells are proposed as a shared target: cells displaying self-antigens, molecular samples from the body's own tissues, from muscle and from hormone-producing tissues. Restoring actual display in 80% of each group, without increasing cell numbers, is predicted to reduce new T lymphocytes, immune cells that mature in the thymus, capable of attacking those tissues. The proposal expects one-group correction or 40% coverage of both groups to be insufficient for the combined benefit.
Rests on: The gap question supplies the search for a defined cell target and a reversible causal link. The endpoint supplies the proposed connection between tissue-specific immune screening and coupled muscle and blood-sugar decline.
AssumptionThe proposal assumes that deficient display in these two groups sustains both forms of decline, that both groups require correction, and that 80% coverage succeeds where 40% does not. These are proposed dependencies to test, not established findings; being untested does not itself make the proposal a leap.
What is carried, and what is not. The screened literature supports the general immune-screening premise: S2, in PloS one (2018), describes the role of thymus cells displaying the body's own molecular samples in preventing self-attack, but does not establish the proposed tissue groups or their restoration; S4, in Proceedings of the National Academy of Sciences of the United States of America (2007), reports evidence in genetically altered mice that failures in removing dangerous developing immune cells can permit self-directed disease without environmental stimulation, but does not establish the proposed muscle effects, coverage requirements or human relevance. No supplied source establishes the sequence from restoring these two groups through improved muscle and blood-sugar function to longer survival.S2S4
Where the reasoning is carried by something unstated · 2
- Gap question. Targeted correction followed by switching off the proposed causal link is adopted as the way to distinguish candidates. The preceding goal does not itself establish this testing requirement.
- Hypothesis. The proposal assumes that deficient display in these two groups sustains both forms of decline, that both groups require correction, and that 80% coverage succeeds where 40% does not. These are proposed dependencies to test, not established findings; being untested does not itself make the proposal a leap.
How a result here could mislead · 3
- An increase in a gene marker, thymus size or newly produced immune cells could be mistaken for restoration of the specific screening function. Conversely, failure to improve function could be blamed on the mechanism even if the intended tissue samples were never displayed. What closes it: The design requires direct confirmation that the two groups display the selected, different tissue samples and that correction reaches the intended fraction of each group while preserving cell numbers. Marker changes alone cannot establish that the intervention occurred.
- Better muscle recovery and blood-sugar control could be credited to reduced self-attack even if the benefits arise through another route. Functional improvement alone also cannot separate this proposal from the supplied liver and hormone-timing rivals. What closes it: Measure newly released immune cells with confirmed reactivity to the selected tissue samples before interpreting later functional changes. Repeat the measurements after switching display off again; the predicted return of those cells must precede gradual loss of benefit, with observation periods fixed in advance.
- Success at 80% coverage could be mistaken for proof that this is the necessary coverage or that these two groups are the smallest sufficient target. An apparent lack of difference from whole-thymus restoration could also reflect an insensitive comparison. What closes it: Compare joint correction with each group alone, 40% coverage and whole-thymus restoration, while verifying achieved display in every condition. Define beforehand what counts as equivalent benefit; these comparisons would test the stated alternatives without locating an exact minimum between the tested coverage levels.
What would make this wrong. The claimed route would be contradicted if verified restoration of the selected tissue-sample display failed to reduce newly released immune cells reactive to those samples, or if restoring their original output after switching display off left the functional benefit intact over the proposed weeks-to-months course. Improvement within hours would also contradict the endpoint's stated timing. Equal combined benefit from one group alone or from 40% coverage would undermine the proposed requirements for both groups and 80% coverage, even if a broader immune-screening mechanism remained possible.
What it would change. If the proposed sequence held, defective immune screening would become a candidate shared cause connecting muscle decline with impaired blood-sugar regulation, and work on a single life-extension target would need to measure tissue-specific screening rather than thymus size alone. The claim that a restricted target is sufficient would depend on the single-group, lower-coverage and whole-thymus comparisons. Even successful functional results would leave longer survival unestablished without a separate survival result, and the supplied endpoint does not specify a study species or establish transfer to humans.
Sources read · 5
Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and cis-Spliced Zwitter Epitope Candidates in Type 1 Diabetes. · Frontiers in immunology · 2021
“We computed in silico viral-human non-spliced and cis -spliced zwitter epitope candidates, and prioritized peptide candidates based on: (i) their binding affinity to HLA class I complexes, (ii) human pancreatic β cell and medullary thymic epithelial cell (mTEC) antigens’ mRNA expression, (iii) antigen association with T1D, and (iv) potential hotspot regions in those antigens.”
Does not settle: Источник не устанавливает утрату презентации собственных антигенов в тимусе, её связь с мышечным или метаболическим снижением, состав двух функциональных групп, охват 80% или 40%, число клеток либо эффект восстановления на возникновение аутореактивных Т-лимфоцитов.
CCR8 is expressed by post-positive selection CD4-lineage thymocytes but is dispensable for central tolerance induction. · PloS one · 2018
“Both mTECs and Sirpα + DC subsets are located in the medulla and play a crucial role in establishing central tolerance through the presentation of self-antigens to maturing SP thymocytes [ ].”
Does not settle: Открытыми остаются презентация антигенов мышечной и эндокринной тканей, состав двух функциональных групп, охват клеток, восстановление презентации, появление аутореактивных Т-лимфоцитов и последствия для двигательных или метаболических нарушений.
“Collectively, these findings indicate that full tolerance induction is largely dependent on substantial Treg-mediated suppression and thymic deletion of alloreactive T cells and may represent general conditions for Treg-mediated transplantation tolerance.”
Does not settle: Источник описывает трансплантационную толерантность в модели мышей с переносом регуляторных Т-лимфоцитов. Он не устанавливает роль эпителиальных клеток мозгового вещества тимуса, презентацию антигенов мышечной или эндокринной тканей, объём восстановления клеток или связь с двигательными и метаболическими нарушениями.
Danger-free autoimmune disease in Aire-deficient mice. · Proceedings of the National Academy of Sciences of the United States of America · 2007
“Together, these data suggest that the stochastic genesis of dangerous T cell clones can initiate autoimmune disease without the need for environmental stimulation, underlining the importance of Aire-dependent thymic deletion.”
Does not settle: Источник подтверждает роль AIRE-зависимой тимусной делеции в запуске аутоиммунитета у мышей. Открытыми остаются презентация антигенов мышечной ткани, размер и состав двух функциональных групп клеток, охват 80% или 40%, сохранение числа клеток, метаболические и двигательные последствия, а также перенос результатов на человека.
Tracing the action of IL-2 in tolerance to islet-specific antigen. · Immunology and cell biology · 2007
“We find that IL-2 is not required for Aire-dependent thymic clonal deletion of high-avidity diabetogenic clones, but is essential for thymic formation of islet-specific Foxp3-expressing CD4 T cells.”
Does not settle: The abstract does not test thymic epithelial-cell restoration, self-antigen presentation by muscle antigens, metabolic or motor decline, the proposed two-group set, 80% or 40% coverage, cell counts, or joint versus single-group correction.
The gap this hypothesis explains
Nothing is known here: the question has not been asked of this system.
Which tissue targets improve multiple systems and lifespan through a shared link rather than separate organ effects?
Original wording · exactly as the pipeline generated it
Какие ткани, клеточные популяции или компартменты содержат общие причинные звенья для самостоятельных идей «серебряных пуль», если адресная коррекция и обратное выключение посредника должны отличить их от конкурирующих мишеней по функциям нескольких систем и продолжительности жизни?
What this question is asking
The question asks where in the body a change could improve several bodily functions and extend life through one shared biological link. It seeks particular tissues, groups of cells, or distinct biological locations where targeted correction produces those benefits, and asks whether subsequently disabling the proposed mediator removes them. The comparison is with competing targets, including targets whose effects act separately on individual organs, using sustained function and lifespan over a common observation period. The question assumes that existing mapping and local interventions identify candidates but have not established a set of shared causal targets; the supplied sources establish only parts of that assumption.
- Tissue, cell population, and biological compartment
- A tissue is an organized part of the body made from cells; a cell population is a group of cells considered together. A compartment is a distinct biological location, such as a region within a cell or a body fluid, and the question asks where the proposed shared cause resides.
- Target and targeted correction
- A target is a biological component or process selected for change. Targeted correction means changing that component in the relevant location; calling it a correction does not establish that it produces a benefit.
- Shared causal target
- A component whose alteration causes effects in several body systems through a common link. A feature found in several tissues is only a candidate until its causal role is established.
- Mediator and mediator dependence
- A mediator is an intermediate part of the chain connecting an intervention to an outcome. Dependence means that the outcome requires that intermediate link; the question asks whether benefits are lost when the link is subsequently disabled.
- Multisystem function
- How well several body systems perform their jobs. Changes in several measured substances are not themselves evidence that several systems function better.
- Lifespan and healthspan
- Lifespan is how long an organism lives. Healthspan concerns time spent in good health or with preserved function, with the exact definition depending on how a study measures it.
- RL-1 and RL-2
- Labels used by the pipeline for levels of mapping and local intervention evidence. Their expansions and criteria are not supplied, so their evidential meaning cannot be established from this input.
- Gene activity
- The use of genetic instructions to make cellular products. S1 concerns regulation of this activity, while S7 measures the abundance of molecular instructions for particular proteins.
- Inflammation
- A set of immune responses involved in responding to damage or threats. Persistent inflammation is one of the processes discussed in the supplied accounts of fasting and communication between fat tissue and the brain.
- Caenorhabditis elegans and hypodermis
- Caenorhabditis elegans is the worm species studied in S2. Its hypodermis is an outer body tissue, compared with muscle in that source's imaging procedures.
- Mitophagy
- The process by which cells remove mitochondria, internal structures involved in energy production. S3 discusses its relationship with stress across ages and cell types rather than establishing a shared life-extending target.
- Ergothioneine
- A dietary antioxidant, meaning a substance associated with limiting certain damaging chemical reactions. S4 reports its increased abundance across tissues but does not establish that this increase causes the desired benefits.
- Plasma
- The fluid portion of blood. It is one of the locations where S4 reports increased ergothioneine.
- UM-HET3 mice
- The named mouse population studied in S4. The supplied results concern males from this population and do not establish the same effects in other populations or species.
- Preprint
- A research manuscript shared before formal journal peer review. S4 and S9 are identified as preprints in the supplied metadata.
- Brain's protective blood barrier
- The boundary that regulates movement of substances between the blood and brain tissue. S6 includes disruption of this boundary among the routes connecting disturbances in fat tissue to the aging brain.
- Heat shock proteins
- A class of proteins involved in helping other proteins maintain or recover their working form. S7 reports different patterns across members of this class and across tissues, so the term does not describe a single uniformly changing target.
- Long-lived dwarf mice
- The small-bodied, long-lived mice described in S7. Their longevity and tissue patterns are observations in that source, not proof that changing heat shock proteins accounts for their lifespan.
- Deoxyribonucleic acid (DNA) and cell-free DNA
- DNA is the molecule that carries genetic information. Cell-free DNA consists of DNA outside cells, including fragments circulating in blood; S8 does not establish which cells supplied the measured circulating material.
- LINE-1 methylation
- Long interspersed nuclear element-1, abbreviated LINE-1, is a class of repeated DNA sequences. Methylation is the attachment of small chemical marks to DNA, and S8 reports age-related loss of these marks at LINE-1 sequences without establishing that the loss causes aging.
- DNA polymerase alpha
- An enzyme involved in copying DNA. S9 concerns changes involving its gene, but the supplied evidence does not establish it as a shared target that extends lifespan.
- Fruit fly, cell lineage, and intestinal stem cells
- The fruit fly is the Drosophila organism studied in the quoted part of S9. A cell lineage comprises cells related through descent, while intestinal stem cells are cells capable of producing replacement cells in the gut.
- Regeneration
- Restoration of damaged or lost tissue. Better regeneration after a particular injury does not by itself demonstrate slower aging or longer lifespan.
- Gut microbial composition
- The makeup of the community of microorganisms living in the gut. S10 explicitly distinguishes changes in that community from demonstrated gains in healthspan.
Existing mapping and local interventions identify candidates but do not establish a set of shared causal targets with distinguishable dependencies, sustained benefits across several systems, and increased lifespan over a common observation period.
Mapping records where biological features occur, while local interventions change a particular tissue or group of cells. The assumption is that such work has produced possible targets without establishing which ones cause benefits across several systems and extend life. If that assumption holds, the unresolved task is distinguishing shared causes from changes that accompany aging or affect individual organs separately.
The supplied material supports the narrower statement that these sources identify tissue patterns and local effects without establishing the complete causal chain requested. S4 reports a shared chemical change across tissues, S8 reports an age-associated change in brain tissue and blood, and S9 reports regeneration and survival during recovery from injury. None of their supplied excerpts establishes the required shared target, mediator dependence, sustained multisystem function, and lifespan benefit together. This bounded source set does not establish that no other literature does so, and the input does not define its RL-1 and RL-2 evidence levels.S4S8S9
The same question asked without the part nothing read establishes:
- Which tissues, cell populations, or biological compartments have evidence that targeted correction improves several bodily functions and lifespan, with those benefits lost after the proposed mediator is disabled?
- What evidence distinguishes a shared causal target for improvements across body systems from separate effects on individual organs?
- A shared target produces the benefits Under the question's proposed mechanism, correcting the target would act through a common mediator to improve several systems and extend life. Losing those benefits when the mediator is disabled would support dependence on that link, while comparison with competing targets would determine whether the shared target offers the claimed advantage.
- Benefits arise through separate organ effects The change could improve different organs through different routes, so disabling one proposed mediator would not account for the whole pattern of benefits. A single shared target would then be an inadequate explanation, and the observed breadth of benefit would not establish that correcting one link reproduces it.
- Local benefits do not extend lifespan A targeted change could improve a tissue measurement or recovery from injury without producing sustained improvements across several systems. If lifespan does not also increase, that outcome would not meet the question's stated requirement for a shared life-extending target.
The proposed chain starts with a targeted change, passes through a mediator, and reaches the functions of several body systems before affecting lifespan. Similar changes in several tissues could identify a shared link, but those observations alone do not establish that the link produces the benefits. If separate organ effects were mistaken for one shared cause, correcting that supposed cause could fail to reproduce the expected breadth of benefit. Likewise, recovery after injury or a change in a measured biological feature does not by itself establish longer life.
Картирование и локальные вмешательства уровней RL-1 и RL-2 выделяют кандидатов, но экспериментального набора общих мишеней не устанавливают.
Установленный набор причинных мишеней с различимыми зависимостями, устойчивой функциональной пользой и положительным выигрышем продолжительности жизни за общий горизонт наблюдения.
Неизвестно, какие локализованные мишени действительно управляют несколькими системами и какие наблюдаемые эффекты объясняются прямым действием на отдельные органы.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Предлагаемый набор состоит из эпителиальных клеток мозгового вещества тимуса, представляющих собственные антигены мышечной и эндокринной тканей. Его определяют по экспрессии и фактической презентации выбранных антигенов, а не по одному маркеру AIRE. Проверяемый размер набора равен двум функциональным группам: восстанавливают презентацию в80%клеток каждой группы, сохраняя исходное число клеток. Предполагается, что совместное восстановление двух групп уменьшает появление новых аутореактивных Т-лимфоцитов, атакующих мышцы и эндокринные ткани, и тем самым ослабляет взаимное усиление двигательных и метаболических нарушений. Коррекция одной группы оставляет второй источник повреждения, а охвата по40%недостаточно для устойчивой проверки созревающих Т-лимфоцитов на оба класса антигенов. Полное восстановление тимуса тогда оказывается больше необходимого набора.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
Совместная коррекция двух групп при охвате80%снижает выход новых Т-лимфоцитов с подтверждённой реактивностью к выбранным собственным антигенам; спустя недели или месяцы улучшаются мышечное восстановление и регуляция глюкозы. Коррекция только мышечной группы даёт преимущественно мышечный эффект, только эндокринной группы даёт преимущественно метаболический эффект, а полный тимусный охват эквивалентен целевому набору. Повторное выключение презентации выбранных антигенов возобновляет появление соответствующих аутореактивных клеток и постепенно устраняет пользу. Немедленное улучшение за часы либо сохранение эффекта при восстановлении исходного выхода аутореактивных клеток противоречит этой гипотезе. Положительный функциональный результат должен сопровождаться отдельным подтверждением выигрыша выживаемости.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable cellular outcomes, comparative functional effects, an equivalence condition, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Специализированные эпителиальные состояния тимуса и антигенспецифические модели отрицательного отбора позволяют проверить идею сначала для ограниченного набора собственных антигенов. Предварительно необходимо показать, что выбранные группы действительно представляют разные антигены и что их адресная коррекция возможна. Общая активация AIRE, рост тимуса или увеличение числа наивных Т-лимфоцитов не будут достаточной проверкой этого набора.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
Совместная коррекция двух групп при охвате 80% снижает выход новых Т-лимфоцитов с подтверждённой реактивностью к выбранным собственным антигенам; спустя недели или месяцы улучшаются мышечное восстановление и регуляция глюкозы. Коррекция только мышечной группы даёт преимущественно мышечный эффект, только эндокринной группы даёт преимущественно метаболический эффект, а полный тимусный охват эквивалентен целевому набору. Повторное выключение презентации выбранных антигенов возобновляет появление соответствующих аутореактивных клеток и постепенно устраняет пользу. Немедленное улучшение за часы либо сохранение эффекта при восстановлении исходного выхода аутореактивных клеток противоречит этой гипотезе. Положительный функциональный результат должен сопровождаться отдельным подтверждением выигрыша выживаемости.
- Rival 01 of 03What would separate them
Errors in liver-made apolipoprotein B may damage blood vessels, muscles and glucose control predicts: В естественно стареющих мышах коррекция указанной половины секреторной продукции улучшает сосудистую реактивность, восстановление мышечной силы и толерантность к глюкозе при сохранении исходных аммиачного профиля, гормональной пульсации и тимусной презентации антигенов. Коррекция четверти продукции не достигает заранее заданных функциональных границ, а увеличение охвата до 75% даёт эквивалентный результат. Возврат выделенной из исходной плазмы фракции липопротеинов с подтверждёнными ошибками в APOB устраняет пользу; контрольная фракция с сопоставимыми липидами и числом частиц её сохраняет. Если эффект объясняется изменением липидного состава либо сохраняется после восстановления исходной нагрузки ошибочного APOB, предложенный посредник отвергается. Продление жизни проверяется отдельно.
- Rival 02 of 03What would separate them
Joint pituitary and adrenal correction may restore hormone pulses and improve multiple functions predicts: Только совместная коррекция двух популяций восстанавливает форму гормональных импульсов и улучшает три функциональные траектории. Коррекция одной популяции либо по 25% клеток каждой не достигает заранее заданной границы; увеличение охвата до 75% эквивалентно 50%. В отдельном опыте замена восстановленного импульсного профиля кортикостерона на исходный возрастной профиль при одинаковой суточной экспозиции устраняет удалённую пользу. Воспроизведение восстановленного профиля у контрольных старых мышей даёт функциональный эффект без коррекции печени или тимуса. Если достаточно одной популяции, гипотеза двухкомпонентного минимума отвергается.
- Rival 03 of 03What would separate them
Restoring ammonia capture near liver veins may preserve muscle and brain function and extend life predicts: После коррекции 80% перивенозных клеток уменьшаются постпрандиальные аммиачные пики, затем улучшаются восстановление мышечной силы и когнитивные показатели. Эти изменения возникают при сохранении исходных точности синтеза APOB, гормональной пульсации и тимусной презентации антигенов. Охват 40% проваливает функциональный критерий при сочетании пищевой и двигательной нагрузок; охват 100% эквивалентен 80%. Повторное выключение глутаминсинтетазы в скорректированных клетках либо восстановление исходного аммиачного профиля отменяет удалённую пользу. Если коррекция нормализует аммиак, но функции и выживаемость продолжают исходную траекторию, набор отвергается как «серебряная пуля».
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
3 quantitative figures appear below and the hypothesis cites no study for any of them. They are the engine's own, and the marks in the text say which.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.